Tissue factor (TF), apart from activating the extrinsic pathway of the blood coagulation, is a principal regulator of embryonic angiogenesis and oncogenic neoangiogenesis, but also influences inflammation, leukocyte diapedesis and tumor progression. The intracellular domain of TF lacks homology to other classes of receptors and hence the signaling mechanism is poorly understood. Here we demonstrate that factor VIIa (the natural ligand for TF) induces the activation of the Src family members c-Src, Lyn, and Yes, and subsequently phosphatidylinositol 3-kinase (PI3K), followed by stimulation of c-Akt/protein kinase B as well as the small GTPases Rac and Cdc42. In turn Rac mediates p38 mitogen-activated protein (MAP) kinase activation and cytoskeletal reorganization, whereas factor VIIa-induced p42/p44 MAP kinase stimulation required PI3K enzymatic activity but was not inhibited by dominant negative Rac proteins. We propose that this Src family member/PI3K/Rac-dependent signaling pathway is a major mediator of factor VIIa/TF effects in pathophysiology.
1 a 47-kDa glycosylated transmembrane protein, is the principal initiator of the extrinsic coagulation pathway, via the binding of factor VII/VIIa, followed by activation of factor X and further hemostasis (1) . In addition, TF is critical for blood vessel development, and TF-deficient mice die as a consequence of abnormalities in this development (2) (3) (4) . Furthermore, TF regulates inflammation, because inhibition of TF/factor VIIa complex assembly dramatically enhanced survival of baboons to LD 100 infusion with Escherichia coli (5, 6) and monocyte diapedesis may involve TF (7) . Finally TF appears to be important in tumor progression, although this effect may well be dependent on the angiogenic properties of TF (8 -10) . The molecular mechanisms, however, by which TF/ factor VII or TF/factor VIIa interactions exert these effects, remain poorly defined.
A first clue as to these mechanisms was provided by Bazan (11) who demonstrated that TF shows substantial homology with the interferon ␣/␤ and ␥ receptors, and this notion was confirmed by crystallographic studies on TF structure (12, 13) . Subsequently, it was demonstrated that factor VIIa/TF interaction exerts a variety of cellular changes, including Ca 2ϩ signaling (14, 15) , tyrosine phosphorylation in monocytes (16) , activation of p42/p44 mitogen-activated protein kinase (MAP kinase) (17) , and changes in gene expression (18) . Hence TF may act as a cellular receptor for factor VII/VIIa, but the molecular details of the subsequent signal transduction as well as how these might relate to the TF action in pathophysiology remain unclear.
A group of proteins possibly involved in TF action is the Rho family of small GTPases, which have an important function in directing cell motility and migration (19) . Recently, it has become clear that especially Rac is important for angiogenesis, calcium signaling, leukocyte migration, and the control of inflammation and oncogenesis, which are functions associated with TF signaling. Furthermore, a recent study by Timokhina et al. (20) has demonstrated that c-Src may act as an upstream regulator of p21 ras , whereas c-Src is a general mediator of signaling of receptors devoid of intrinsic kinase activity like TF. We decided to study, therefore, the role of Rac and the Src-like tyrosine kinases in TF signaling. The results show that TF/ factor VIIa interaction stimulates a signaling pathway involving the activation of Src-like family members c-Src, Lyn, and Yes, and subsequently PI3K leading to the stimulation of p42/ p44 MAP kinase, c-Akt/PKB, and Rac. In turn, the latter GTPase provokes cytoskeletal reorganization and p38 MAP kinase activation. We propose, that this c-Src-, PI3K-, and p21 rac -dependent signaling pathway is a major mediator of TF effects in pathophysiology.
MATERIALS AND METHODS
Reagents and Antibodies-p42/p44 MAP kinase, phosphospecific p42/p44 MAP kinase, Ser 473 -cAkt/PKB, and p38 MAP kinase antibodies were purchased from New England BioLabs. Rac, Fyn, Lyn, Yes, Src, and immobilized SAM68 (Src-Associated in Mitosis) antibodies were obtained from Santa Cruz, horseradish peroxidase-conjugated goatanti-rabbit, and goat-anti-mouse antibodies were purchased from ITK Diagnostics. Phalloidin-TRITC, "COMPLETE" protease inhibitor, forskolin, nordihydroguaretic acid (NDGA), purified factor X, human thrombin, and wortmannin were obtained from Sigma. Plasma-purified factor VIIa and the MEK-inhibitor PD98059 were purchased from Alexis. Recombinant factor VIIa was from Novo Nordisc. The Src-* This study was supported in part by a grant (UVA 98-1855) from the Dutch Cancer Society (Koningin Wilhelmina Fonds). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by an Ambrosius fellowship. ** To whom correspondence should be addressed: Tel.: 31-20-566-5910; Fax: 31-20-697-7192; E-mail: m.p.peppelenbosch@amc.uva.nl. 1 The abbreviations used are: TF, tissue factor; MAP kinase, mitogenactivated protein kinase; NDGA, nordihydroguaretic acid; PAK, p21-activated kinase; PI3K, phosphatidylinositol 3-kinase; PIP, phosphatidylinositol phosphate; PIP 2 , phosphatidylinositol bisphosphate; PIP 3 , phosphatidylinositol-3,4,5-trisphosphate; PKB, protein kinase B; TNF␣, tumor necrosis factor ␣; MEK, mitogen-activated protein kinase/ extracellular signal-regulated kinase kinase; PBS, phosphate-buffered saline; EGF, epidermal growth factor; PAGE, polyacrylamide gel electrophoresis; TLC, thin layer chromatography; JNK, c-Jun N-terminal kinase; PAR, protease-activated receptor.
inhibitor PP1 was acquired from Biomol, and recombinant hirudin was obtained through Fluka.
Cell Culture-A14, Cos, Rat1, and 293 cell lines were cultured according to routine procedures. Expression of RacN17 in stably transfected Rat1 cells was inhibited with 1 g of tetracycline/ml of medium (21, 22) . Inhibition of PI3K was performed by adding wortmannin to a final concentration of 100 nM (23) . Inhibition of MAP kinase was performed using forskolin in a final concentration of 2 M (24) or PD98059 in a final concentration of 10 M (25). Rho activation was inhibited by treatment of cells with 20 M NDGA (21) . NDGA, wortmannin, forskolin, and PD98059 were added 10 min prior to the experiment. The tyrosine kinases of the Src family were inhibited by adding PP1 to a final concentration of 20 M 30 min prior to the experiment. Factor VIIa was added in a final concentration of 10 g/ml for 10 min.
Immunofluorescence Experiments-Cells were grown on glass coverslips and serum-starved for 24 h. After appropriate incubation, the cells were washed with PBS and fixed with 4% formaldehyde in PBS for 20 min at 4°C. The cells were lysed and blocked with 0.1% bovine serum albumin in PBS, supplemented with 0.1% Triton X-100 for 1 h and stained with phalloidin-TRITC, diluted to a final concentration of 10 g/ml (1:100) in PBS, supplemented with bovine serum albumin and Triton X-100 for 1 h. The coverslips were washed with PBS, mounted with glycerol-gelatin, and examined under a fluorescence microscope.
Rac/Cdc42 Activation Experiments-Rac activation experiments were performed as described by Sander et al. (26) , with some modifications. A bacterially expressed fusion protein was used, consisting of an N-terminal glutathione S-transferase part and a C-terminal part containing an amino acid sequence matching the Rac-GTP-binding domain of PAK. Bacterial cultures were grown to an A 600 of 0.6 after centrifugation and lysed in PBS containing 100 mM EDTA and 1% Triton X-100 with freshly added COMPLETE, and fusion proteins were isolated with glutathione-agarose. After appropriate stimulation, cell lysates were prepared by scraping in Fish buffer (20 mM Tris, pH 7.4; 10% glycerol; 1% Nonidet P-40; 100 mM NaCl; 2 mM MgCl 2 ). Per 300 l of cell lysate, 100 l of 50% slurry was added, and this was incubated for 30 min at 4°C. Beads were isolated and washed extensively and resuspended in 2ϫ sample buffer (125 mM Tris-HCl, pH 6.8; 4% SDS; 2% ␤-mercaptoethanol; 20% glycerol, 1 mg of bromphenol blue). Rac and Cdc42 activation was assessed using SDS-PAGE and immunoblotting employing a Rac antibody and chemiluminescence.
SAM68 Phosphorylation Assay-Serum-starved A14 cells, grown in 10-cm dishes, were incubated with factor VIIa for various times, washed in ice-cold PBS, and lysed in 0.5 ml of a non-denaturing lysis buffer (10 mM Tris-HCl, pH 7.4; 50 mM NaCl; 50 mM NaF, 2 mM MgCl 2 ; 1 mM CaCl 2 ; 1% Triton X-100; 100 M Na 3 VO 4 ; 1.5 mg/ml COMPLETE). The lysates were centrifuged for 10 min at 13,000 rpm, and ATP (200 M) and SAM68 (2 g/ml) were added. The reaction was performed at 30°C for 30 min. Subsequently, SAM68 was immunoprecipitated by incubating the samples with a Sepharose-conjugated polyclonal SAM68 antibody for 1 h at 4°C. The immunoprecipitate was loaded on a 10% SDS-PAGE and immunoblotted with PY20. The specificity of the assay for Src-like kinase enzymatic activity was demonstrated by the sensitivity of the assay to the Src-like kinase inhibitor PP1 (not shown).
Activation of different Src family members was determined after stimulation for 7.5 min with factor VIIa. Subsequently, the cells were washed with cold PBS and lysed in 0.5 ml of non-denaturing lysis buffer. After centrifugation, 0.25 ml of the lysate was precleared with 40 l of 50% protein A-Sepharose for 1 h at 4°C and incubated with 1 g of Src, Fyn, Lyn, or Yes antibodies for 4 h at 4°C. The lysates were incubated with 40 l of 50% protein A-Sepharose for 1 h at 4°C and centrifuged for 1 min at 6000 rpm. The beads were washed twice with lysis buffer and once with kinase buffer (25 mM Tris, pH 7.5; 5 mM ␤-glycerolphosphate; 2 mM dithiothreitol; 0.1 mM Na 3 VO 4 ; 10 mM MgCl 2 ). Subsequently, the beads were resuspended in 50 l of kinase buffer supplemented with 2 g of SAM68 and 200 M ATP. The kinase reaction was performed at 30°C for 30 min, either in the presence or absence of PP1, and studied using 10% SDS-PAGE and probing with PY20.
Phosphoinositide Measurements-A14 cells were grown in 12 wells in inositol-free DMEM (Life Technologies, Inc.), supplemented with 1% inositol-free fetal calf serum, until 40% confluence. The cells were labeled for 2 days with 10 Ci of [ 3 H]inositol. Subsequently, the cells were serum starved for 4 h and stimulated with factor VIIa. The cells were scraped in 1 ml of methanol at Ϫ20°C, and lipids were extracted by adding 0.5 ml of HCl/H 2 O (1:50) and 1 ml of chloroform. The chloroform fraction was isolated and vaporized. The remainder was dissolved in 50 l of chloroform/methanol/H 2 O (72:25:2) and spotted on TLC plates. The TLC plates were run in chloroform/methanol/water (90:70:20) containing 4.3 M NH 4 OH. A TLC scanner was used to determine the relative amounts of PIP, PIP 2 , and PIP 3 .
p38 MAP Kinase, PKB, and p42/p44 MAP Kinase Analysis-For analysis of PKB, p38 MAP kinase, and p42/p44 MAP kinase activation, cells were serum-starved for 24 h and appropriately stimulated, washed with ice-cold PBS, and scraped in 150 l of 2ϫ sample buffer. 50-l samples were loaded on SDS-PAGE and analyzed after immunoblotting, using phosphospecific antibodies. Equal loading was verified by Coomassie Brilliant Blue staining. Chemiluminescence was performed and detected as described earlier.
Chromogenic Substrate Analysis-Human thrombin or factor VIIa were diluted in Tris-buffered saline (25 mM Tris, 150 mM NaCl, pH 7.4) to 1 unit/ml or 10 g/ml, respectively. The dilutions were either left untreated or preincubated with 4 units/ml hirudin for 10 min. The final volume was brought to 100 l. 25 l of chromogenic substrate (Chromogenix) was added, and the reaction was monitored for 5 min at 37°C, using an enzyme-linked immunosorbent assay reader at A 405 . Subsequently, the V max value was determined for all reactions.
Cell Transfections-HEK 293 cells were transfected with the construct 10.3-hTF (kindly provided by Dr. H. ten Cate) containing fulllength human tissue factor, using Fugene 6 from Roche Molecular Biochemicals. Transfections were performed as recommended by the manufacturer.
RESULTS

Addition of Factor VIIa to Fibroblasts Results in Filopodia
and Lamellipodia Production-Both blood vessel formation and cell migration are regulated by TF and are typically associated with cytoskeletal alteration, and a recent study by Ott et al. (27) has shown that TF/factor VIIa interaction results in actin reorganization. To obtain more insight into the effects of TF, we made use of an A14 fibroblast system, because fibroblasts are well known for their constitutive expression of TF (e.g. see Ref. 28) . Therefore, we stimulated A14 cells with human factor VIIa for various time periods and investigated changes in the actin cytoskeleton. In agreement with the observations of Ott et al. (27) , we observed substantial actin stress fiber formation in response to factor VIIa. It is well established, however, that stimulus-induced stress fiber formation may mask other actin reorganization events, like ruffling, lamellipodia, and filopodia (29, 30) , that are more related to cell migration than to stress fiber formation (31) . Therefore, we treated cells with NDGA, which impairs the stress fiber-inducing GTPase Rho (22) . Subsequent stimulation with factor VIIa, indeed, revealed the formation of filopodia (Fig. 1, C, E, G, I , K, and L) and both lamellipodia (Fig. 1, D, F , H, J, and K) and membrane ruffles (Fig. 1L ), structures associated with activation of Cdc42 and Rac, respectively. These observations indicate, therefore, that TF/factor VIIa signal transduction involves both Rac-and Cdc42-dependent signaling.
Factor VIIa-induced Activation of Rac and Cdc42 Is Sensitive to the Src Family Member and PI-3 Kinase Inhibitors PP1
and Wortmannin-We directly tested the effects of factor VIIa addition to fibroblasts on Cdc42 and Rac using the association of p65PAK to Rac and Cdc42. Because p65PAK binds only to the GTP-bound forms of these proteins, such binding represents activation of Rac and Cdc42 (32) . This type of assay was used successfully to demonstrate Rap1 activation in human neutrophils (33) and Rac activation by Tiam (26) . We observed enhanced levels of activated Cdc42 and Rac in lysates of factor VIIa-stimulated cells. This response was comparable to the response induced by TNF␣ and insulin, well known activators of Cdc42 and Rac (29, 34 -36) (Fig. 2) . These experiments confirm, therefore, the activation of Rac and Cdc42 by factor VIIa in fibroblasts, as was inferred from the effects on cytoskeletal organization. We also tested the effect of various pharmacological inhibitors on Rac and Cdc42 activation. Importantly, both PP1 and wortmannin, specific inhibitors of Src-like kinases (37) and PI3K, respectively (23), abolished factor VIIa activation of Cdc42 and Rac (Fig. 2) , suggesting that Src-like kinases and PI3K are required for the Cdc42 and Rac activation in response to factor VIIa.
Factor VIIa Treatment of Cells Leads to Activation of c-Src, Lyn, and Yes but Not Fyn-The observation that pharmacological inhibitors of Src-like kinases impair factor VIIa-dependent Cdc42 and Rac activation suggests that such kinases participate in TF/factor VIIa signal transduction. Therefore, we directly assessed enzymatic activity of these enzymes using the in vitro phosphorylation of the Src family substrate SAM68 (38, 39) as a readout. As shown in Fig. 3A , the SAM68-phosphorylating activity is enhanced in lysates obtained from factor VIIatreated A14 cells, a maximal effect being reached after 7.5 min. These results demonstrate that an Src-like kinase is activated in response to factor VIIa. To assess the nature of the Src family member involved, several of these kinases were immunoprecipitated and subjected to a similar in vitro kinase assay. As shown in Fig. 3B , an antibody directed against the c-Src homologue Fyn did immunoprecipitate SAM68-phosphorylating enzymatic activity, but this activity was not enhanced in factor VIIa-treated cells. In contrast, immunoprecipitation of Yes revealed strongly enhanced kinase activity in factor VIIatreated cells (Fig. 3B) , whereas also c-Src and Lyn showed some increased activity. The specificity of the assay was demonstrated by its sensitivity to PP1 (Fig. 3B) . We concluded that factor VIIa treatment of cells leads to activation of Yes and to a lesser extent c-Src and Lyn, whereas Fyn is not a target for factor VIIa-dependent signal transduction.
Factor VIIa Produces PP1-sensitive PI3K Activation-Subsequently, we assayed the effects of factor VIIa on phosphoinositide formation. As shown in Fig. 4 , cellular PIP, PIP 2 , and PIP 3 levels transiently increase after TF/factor VIIa interaction. The specificity of the latter response was demonstrated by its sensitivity to wortmannin (not shown). To confirm PI3K activity, we assessed c-Akt/PKB activation. The latter kinase is a well known downstream target for PI3K and, as shown in Fig. 5 , factor VIIa strongly enhances the Ser 473 phosphorylation of c-Akt/PKB. This activation was sensitive to both the Src family inhibitor (PP1) and wortmannin, suggesting that Src-like kinases act upstream of PI3K in our experimental system. Together these data establish PI3K and c-Akt/PKB as mediators of TF/factor VIIa signaling, downstream of a Src-like kinase.
Factor VIIa Activates p38 MAP Kinase in a Rac-dependent Fashion, but Not JNK-The notion, that an Src-like kinaseand PI3K-dependent signaling pathway mediates the factor VII-induced activation of Rac and further downstream signaling, was confirmed by experiments investigating the phosphorylation state of p38 MAP kinase. Rac is a well known activator of p38 MAP kinase (40, 41) and, as depicted in Fig. 6A , addition of factor VIIa to cells resulted in increased phosphorylation of p38 MAP kinase, comparable to that mediated by insulin, an activator of p38 MAP kinase in many cells (42, 43) . This increase was sensitive to preincubation with either wortmannin or PP1. Furthermore, in cells expressing the dominant negative RacN17 (30), factor VIIa did not activate p38 MAP kinase (Fig. 6B) , whereas in the Rat1 parental cell line, from which the RacN17 cell line is derived, factor VIIa-mediated p38 MAP kinase activation was readily detected. Another possible Rac target is JNK, and we also assessed possible activation of JNK in our system. However, as shown in Fig. 6C , JNK is not a target of factor VIIa/TF-mediated signaling. We concluded that the Src/PI3K/Rac-signaling module mediates p38 MAP kinase activation but not JNK activation after exposure of cells to factor VIIa.
Factor VIIa-induced p42/p44 MAP Kinase Requires an Srclike Kinase and PI3K but Not Functional Rac-Addition of factor VIIa to TF-transfected cells was earlier shown to result in activation of p42/42 MAP kinase (17) . p42/p44 MAP kinase stimulation by several receptors lacking intrinsic enzymatic activity has been shown to involve Src family members in lymphoid cells (44) , although such a role for c-Src family members in non-lymphoid cells remains poorly defined. Therefore, we decided to test whether stimulation of p42/p44 MAP kinase by factor VIIa involved a c-Src-like non-receptor tyrosine kinase. Addition of factor VIIa was capable of mediating a PP1-sensitive p42/p44 MAP kinase phosphorylation (Fig. 7) . Also, wortmannin abolished the factor VIIa-induced p42/p44 MAP kinase phosphorylation (Fig. 7A) ; hence, PI3K is required for this activation. Rac, however, is not essential for factor VIIainduced p42/p44 MAP kinase activation, because in Rac N17-expressing cells stimulation of this kinase is readily observed (Fig. 7C) . We also tested the effect of forskolin treatment (which inhibits c-Raf (24 and references therein)) and PD98059 (a specific inhibitor of the MAP kinase kinase MEK (25)). Both conditions resulted in abrogation of VIIa-dependent MAP kinase phosphorylation (Fig. 7B) . Our data suggest, therefore, a triple function for the c-Src/PI3K signaling module factor VIIa in its effects on cellular physiology: activation of c-Raf and MEK, probably via Ras, to produce phosphorylation of p42/p44 MAP kinase, activation of c-Akt/PKB, and stimulation of Rac for producing cytoskeletal reorganization and p38 MAP kinase activation.
Factor VIIa/TF-specific Signaling-To exclude the possibility that the observed activation of the signal transduction components was induced by contamination of our factor VIIa with other coagulation proteins, such as thrombin or factor Xa, we incubated A14 fibroblasts with human thrombin, factor Xa, or human recombinant factor VIIa. As demonstrated in Fig. 8 , neither human thrombin (factor IIa) nor factor Xa mimicked plasma-purified factor VIIa p42/p44 MAP kinase activation and recombinant factor VIIa was as active in our assays as was purified factor VIIa. In addition, the effectors of the TF-induced c-Src/PI3K signaling module identified in this study (c-Akt/ PKB, p38 MAP kinase, p42/p44 MAP kinase) were not affected by a 30-min preincubation with hirudin at concentrations (25 units/ml) that impaired thrombin-induced p42/p44 MAP stimulation (Fig. 9) . Altogether, these data indicate that these signals were specific for factor VIIa/TF interaction and were not caused by interfering contaminants. DISCUSSION TF has important coagulation-dependent and coagulationindependent functions. The latter include the regulation of angiogenesis (2-4), leukocyte migration (7), and inflammation (5, 6) . The molecular details of the underlying signaling pathways, induced by TF/factor VIIa interaction, are still obscure. Because many of the cellular effects of TF involve cytoskeletal reorganization, we investigated the role of Cdc42 and Rac proteins, both important regulators of actin remodeling (29, 30) . We demonstrated that addition of factor VIIa to fibroblasts resulted in formation of filopodia and both lamellipodia as well as membrane ruffles, structures that are thought to be highly indicative for Cdc42 and Rac activation, respectively. In agreement, direct activation of both GTPases in response to factor VIIa was observed using an assay relying on the specific interaction of p65PAK with Rac and Cdc42. Interestingly, activation of these GTPases was sensitive to inhibition of Src-like kinases and PI3K, and we investigated the role of these signaling elements in factor VIIa action. We observed activation of the Src-like kinases Yes, Lyn, and c-Src, and we observed stimulation of PI3K. Interestingly, the latter response was sensitive to PP1 and thus Src-like kinases appear to act upstream of PI3K. This suggests that the recently described (c-Kit receptor- FIG. 3 . Activation of Src-like kinases by factor VIIa. A, factor VIIa-induced Src activation was measured by incubating lysates, prepared from cells treated with purified human factor VIIa for the indicated times, with ATP and the Src substrate SAM68. After incubation, SAM68 was immunoprecipitated, loaded onto a 10% SDS-PAGE, and immunoblotted with PY20. B, A14 fibroblasts were serum-starved and stimulated with factor VIIa for 7.5 min. The Src family members c-Src, Lyn, Fyn, and Yes were immunoprecipitated and used for an in vitro kinase assay either in the presence or absence of the Src-like kinase inhibitor PP1. The phosphorylated substrate, SAM68, was immunoblotted and detected with PY20. Lanes 1 and 3 show Src family activity in serum-starved cells; lanes 2 and 4 represent activation states after 7.5 min of factor VIIa stimulation. Lanes 3 and 4 show phosphorylation activity of the Src-like kinases in the presence of PP1 induced) signaling pathway involving the sequential activation of c-Src and PI3K leading to the activation of Rac (20) also mediates factor VIIa stimulation of the Rac GTPase and that this pathway is also capable of activating Cdc42.
A role for PI3K upstream of Rac and Cdc42 is in agreement with the insight that this enzyme is a principal regulator of the actin cytoskeleton (45) via the activation of Rac-like proteins (46, 47) . We hypothesize, therefore, that the effects of factor VIIa on angiogenesis and monocyte migration involve a factor VIIa-dependent stimulation of Rac and Cdc42 and subsequent cytoskeletal reorganization. Furthermore, because Rac and Cdc42 are involved in tumorigenesis (22, 48 -50) , Rac and Cdc42 activation by factor VIIa may be implicated in tumorigenic effects associated with TF. The connection between TF signal transduction and the small GTPases of the Rho family may mediate important aspects of TF action in pathophysiology.
Next to cytoskeletal rearrangements, Rac is implicated in the activation of p38 MAP kinase (40, 41) . We found enhanced p38 MAP kinase phosphorylation upon factor VIIa stimulation, which was sensitive to RacN17. Hence Rac-mediated p38 MAP kinase functions as an effector for factor VIIa, possibly by linking TF action to inflammation.
TF-mediated activation of p42/p44 MAP kinase was first reported by Poulsen et al. (17) , using TF-transfected baby hamster kidney cells, a cell type that normally does not express TF. This MAP kinase activation was dependent on MEK and factor VIIa protease activity. In accordance, MAP kinase activation observed in A14 cells was also dependent on MEK activity, whereas the sensitivity of this response forskolin also indicates that c-Raf is involved in MAP kinase stimulation. We observed that PI3K and Src mediated this MAP kinase activation. In addition, the Src-like kinase/PI3K signaling module is responsible for c-Akt/PKB phosphorylation. c-Akt/PKB is a well known downstream target of PI3K (51), and its activation thus further confirms PI3K activation by factor VIIa. Because the Src-like kinase/PI3K signaling module seems essential for stimulation of p42/p44 MAP kinase, the GTPases Rac and Cdc42, and c-Akt/PKB, we propose that this signaling module fulfills a key function in factor VIIa signal transduction.
The nature of the Src-like kinase mediating PI3K activation remains obscure. We observed factor VIIa-dependent increased enzymatic activity of Lyn, c-Src, and in particular Yes, whereas Fyn was clearly not activated by factor VIIa. However, Yes, c-Src, and Lyn were all sensitive to PP1 in vitro, and this inhibitor may therefore inhibit activation of these kinases in vivo (although inhibition of Yes by PP1 in vivo has not been . Cell lysates were loaded onto a 10% SDS-PAGE and immunoblotted with phosphospecific p38 MAP kinase antibody. B, both A14 cells and Rat-1 cells expressing the dominant negative RacN17 were serum-starved and stimulated with factor VIIa for the indicated times. Cell lysates were loaded onto a 10% SDS-PAGE and immunoblotted with phosphospecific p38 MAP kinase antibody. C, A14 cells were stimulated with factor VIIa for the indicated times, and lysates were subjected to Western blot analysis with phosphospecific JNK antibodies. reported). Therefore, it remains unclear whether only one or possibly more of these kinases are responsible for the activation of the PI3K/Rac/p38 MAP kinase and the PI3K/p42/p44 MAP kinase modules. Moreover, roles for c-Src, Lyn, and Yes upstream of PI3K have all been reported (52) (53) (54) (55) (56) (57) , and the nature of the Src-like kinase upstream of PI3K awaits, therefore, further experimentation.
Both p42/p44 MAP kinase and p38 MAP kinase show an initial decrease in phosphorylation during the first 5 min of stimulation with factor VIIa, before an increase in phosphorylation occurs after 10 min. We do not currently know which signal transduction components are responsible for this effect, but it is tempting to speculate that a TF/factor VIIa-activated phosphatase is responsible for this effect. As activation of tyrosine phosphatases is well known to be essential for activation of c-Src-like kinases (58) , stimulation of such phosphatases is not entirely unexpected. It would be interesting to determine the identity and the involvement of such phosphatases, and experiments addressing this issue are currently being performed in our laboratory.
Recently, Sørensen et al. (59) suggested the involvement of an additional transmembrane protein, involved in factor VIIa/ TF-dependent signaling. Factor VIIa uses TF as a docking site rather than as a receptor, and subsequently, it proteolytically cleaves an as yet unknown protease-activated receptor (PAR).
So far, only four PARs have been identified (PAR-1 through PAR-4), and three of them, PAR-1, -3, and -4, are activated by thrombin. This might explain the similarities found between thrombin-and factor VIIa/TF-dependent signaling. Cells were preincubated for 30 min with 25 units/ml hirudin after which cells were subjected to 10 g/ml factor VIIa for 15 min (A). The subsequently prepared cell lysates were assayed for phosphorylation of p42/ p44 MAP kinase, p38 MAP kinase, and PKB phosphorylation with phosphospecific antibodies on Western blot. Lane 1 represents the vehicle control, lanes 2 and 4 represent cells pretreated with hirudin, and lanes 3 and 4 represent factor VIIa-stimulated cells. B, to validate the potency of hirudin, cells were again pretreated with hirudin for 30 min and incubated with 1 unit/ml thrombin for 5 min. The lysates were probed for phosphorylated MAP kinase with phosphospecific antibodies on Western blot. Lane 1 represents the vehicle control, lanes 2 and 4 represent cells pretreated with hirudin, and lanes 3 and 4 represent thrombin-stimulated cells.
